QUOTE AND NEWS
StreetInsider.com  Mar 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Nymox+%28NYMX%29+Reports+Strong+Data+from+Follow-Up+Assessment+of+NX-1207+in+BPH+Patients/7295480.html for the full story.
Benzinga  Feb 15  Comment 
Nymox Pharmaceutical Corporation (Nasdaq: NYMX) provided an update today on the Company's Phase 3 U.S. trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of February 14,...
StreetInsider.com  Nov 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Nymox+%28NYMX%29+Reports+No+Significant+Safety+Concerns+from+Two+Pivotal+NX-1207+Phase+3s/6970613.html for the full story.
StreetInsider.com  Oct 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Nymox+Pharma+%28NYMX%29+Reports+Statistical+Significance+Achieved+on+NX-1207+Phase+2+Follow+Ups/6867972.html for the full story.
StreetInsider.com  Apr 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Nymox+%28NYMX%29+Reports+Positive+NX-1207+Follow-Up+Data/6426162.html for the full story.
TheStreet.com  Feb 10  Comment 
HASBROUCK HEIGHTS, N.J. (TheStreet) -- Three and a half years ago, I knocked Nymox Pharmaceutical for hyping the prospects for an experimental prostate enlargement drug NX-1207 without divulging much information about the drug or how it was...
MarketWatch  Dec 17  Comment 
MarketWatch’s daily roundup of shares making the biggest moves.
StreetInsider.com  Dec 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Recordati%2C+Nymox+Pharma+%28NYMX%29+report+European+licensing+pact+for+NX-1207%3B+Recordati+to+make+upfront+payment+of+%2413M/6169234.html for the full story.
Globe Newswire  Nov 29  Comment 
HASBROUCK HEIGHTS, N.J., Nov. 29, 2010 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce that the Company has secured commitment for $15 million in equity financing from institutional investors. The new funding
StreetInsider.com  Nov 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Nymox+Pharma+%28NYMX%29+Awarded+%24244.5K+from+QTDP+for+NX-1207+Ongoing+Phase+III/6072394.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki